Clinical trials have shown weight loss of approximately 12-15% of body weight with semaglutide and 5-8% with liraglutide over 12-18 months when combined with lifestyle modifications
Retatrutide is a once-weekly subcutaneous peptide that simultaneously activates GIP, GLP-1, and glucagon receptors
One of our qualified healthcare professionals will be more than happy to provide personalised guidance and support, ensuring you feel confident and well-supported throughout your treatment journey
Dosing flexibility differs between medications, with tirzepatide offering more granular titration options through its injection format
Ce produit innovant convient tous les types de peau, y compris les peaux noires et mtisses
has received consulting honoraria from Anii Pharmaceuticals, Boehringer Ingelheim, Eli Lilly, Merck, Novo Nordisk and Oramed, and stock options from Altpep